Marcin Czech, deputy minister and undersecretary of state at the Polish Ministry of Health, provides an in-depth perspective on Poland’s drug policy framework and the new medicines policy that aims to integrate pharmacoecomonics to ensure Poland can find an efficient balance between innovative and generic treatments for long-term stability. Furthermore, he discusses the implications of the new Reimbursement Act and his unique journey into his newly appointed role. You have just been recently appointed as the Deputy Minister of Health and Undersecretary of State. What is your mandate?
"Overall, we want to create a more stable system that does not fluctuate so rapidly; therefore, the reimbursement list will be launched each quarter, rather than the current bimonthly release."